Lazard Asset Management LLC Acquires Shares of 18,970 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Lazard Asset Management LLC acquired a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 18,970 shares of the company’s stock, valued at approximately $122,000. Other institutional investors and hedge funds have also recently modified […]
Lazard Asset Management LLC acquired a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 18,970 shares of the company’s stock, valued at approximately $122,000. Other institutional investors and hedge funds have also recently modified […]
